Advanced Search

 

Study ID Status Title Patient Level Data
123-037 Completed A Randomised, Double-Blind, Controlled Study of Valaciclovir for the Suppression of Recurrent Genital Herpes Simplex Virus Infection in Immunocompetent Patients
123-038 Completed Evaluation of the Effect of an Aluminium Hydroxide and Magnesium Hydroxide Containing Antacid on the Pharmacokinetics of Valaciclovir and Acyclovir Following a Single Oral Dose of Valaciclovir
123-044 Completed Pharmacokinetics of valaciclovir in late pregnancy
123-304 Completed Zoster ophthalmicus in immunocompetent patientsExtensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication. See citation below.
123-310 Completed A double-blind, multicenter study comparing valacyclovir HCL with famciclovir for the treatment of uncomplicated herpes zoster in immunocompetent patients 50 years of age and olderExtensive searching has revealed that no clinical study report is available for this study.
13 Completed Ninety-eight day, parallel, double-blind, randomized comparison of placebo, bupropion and amitriptyline (75-200mg/day) in outpatients, ages 55 and older – Extensive searching has revealed that no clinical study report is available for this study.
134612/003 Completed Assess the safety, reactogenicity, immunogenicity & long-term persistence of one intramuscular dose of GSK Biologicals' MenACWY conjugate vaccine vs one subcutaneous dose of Mencevax™ ACWY in healthy adults aged 18-25 yrs Study Listed on ClinicalStudyDataRequest.com
134612/004 Completed A Phase II, open (partially double-blind), randomized, controlled dose-range study to evaluate the immunogenicity, reactogenicity and safety of investigational vaccination regimens versus a licensed MenC vaccine or Mencevax™ ACWY when given in children aged 12 to 14 months and 3 to 5 years old Study Listed on ClinicalStudyDataRequest.com
134612/005 Completed A Phase II, open (partially double-blind), randomized, controlled dose-range study to evaluate the immunogenicity, reactogenicity and safety of investigational vaccination regimens versus Mencevax ACWY when given in children aged 3 to 5 years old Study Listed on ClinicalStudyDataRequest.com
14 Completed Phase II Multicenter Evaluation of the Efficacy and Safety of Bupropion vs. Placebo in Depressed Inpatients
14777/262 Completed An open-label study assessing the population pharmacokinetics, safety and efficacy of nabumetone in patients with juvenile rheumatoid arthritis (JRA) requiring NSAID therapy.
14777/267 Completed A Randomized, Double-Blind, Placebo-Controlled, Endoscopic Study to Assess the Gastroduodenal Effects of an Investigational Formulation of Nabumetone, Relafen, Naproxen Sodium, and Placebo Administered to Healthy Subjects.
14777/268 Completed A Single Dose Study to Evaluate the Dose Proportionality of the Tablet Formulation of Nabumetone Q and the Relative Bioavailability of Nabumetone Q Compared to RELAFEN in Healthy Subjects
14777/269 Completed An evaluation of the COX-1 and COX-2 inhibitory activity of four potential clinical doses of nabumatone (NAB) Q, relative to repeat doses of naproxen sodium 550mg, rofecoxib 50mg, and Relafen 2000mg.
14777/275 Completed A Study to Determine the Steady State Pharmacokinetics of Total and Unbound 6-Methoxy-2-Napthylacetic Acid (6-MNA) After Repeat Doses of the Tablet Formulation of Nabumetone Q and Commercial Relafen (1000 mg and 2000 mg each UID) in Healthy Subjects.
15 Completed Thirteen week, parallel, double blind, randomized comparison of bupropion versus amitriptyline (75-100mg/day) in outpatients– Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citations below.
159797/001 Completed A multi-centre, randomised, double-blind, placebo controlled, crossover study to examine the efficacy, safety, tolerability and systemic pharmacokinetics profile of single inhaled dose of a new chemical entity, salmeterol and placebo in asthmatic subjects.
16 Completed Double-Blind Comparison of Doxepin versus Bupropion in Outpatients with a Major Depressive Disorder – Extensive searching has revealed that no clinical study report is available for this study. The clinical trial results were reported via publication; see citation below.
196131/001 Completed A phase III, partially double blind, randomized, multicentric study to evaluate the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals Kft’s combined DTPwCSL-HB vaccine as compared to Commonwealth Serum Laboratory’s (CSL’s) DTPwCSL (Triple Antigen™) and GSK Biologicals’ HBV (Engerix™-B) administered concomitantly at separate injection sites and to GSK Biologicals’ DTPw-HB vaccine (Tritanrix™-HepB) when administered to healthy infants at 3, 4 and 5 months of age Study Listed on ClinicalStudyDataRequest.com
1991_Dataset Completed Analysis of suicide attempts in paroxetine clinical trials for the adult clinical trial population
200016 Completed An Open-Label Exploratory Study to Investigate the Feasibility of Administering Exenatide by Continuous Subcutaneous Infusion to Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
200017 Not yet recruiting A Questionnaire based Survey of Psychiatrists practicing in India to Determine their Diagnostic and Management Practices for Bipolar Disorders in Clinical Practice
200030 Completed A Pilot Study in Healthy Male Volunteers to Evaluate a Skeletal-Muscle Microbiopsy Technique for Suitability of Use with Dynamic Proteomic Measurement
200065 Completed Glucagon-like peptide-1 (GLP-1) agonists: Treatment utilization patterns and risk of acute pancreatitis
200072 Completed An Open-label Study to Evaluate the Effects of a Potent CYP3A4 Inducer and the Effects of a pH Elevating Agent on the Repeat Dose Pharmacokinetics of Dabrafenib (GSK2118436) in Subjects with BRAF V600 Mutation Positive Tumors

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.